Neurocrine Biosciences, Inc. (NBIX) — Hedge Fund Ownership Q4 2025
NBIX
- Neurocrine Biosciences, Inc. (NBIX) is held by 1 of 82 tracked hedge funds, with Dodge & Cox (0.4%) holding the largest stake, indicating limited hedge fund interest relative to peers.
- The biggest decreases in NBIX holdings came from Dodge & Cox (-1%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to Neurocrine Biosciences, Inc. (NBIX) by -1% vs the prior quarter and +83% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
|
0.42% | 5.5M | -0.87% | +82.60% | $781.2M | $141.83 | — |
| 1 | Total | — | 5.5M | -0.87% | +82.60% | $781.2M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.